Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/14/2014US20140227199 Penetrating pharmaceutical foam
08/14/2014US20140227197 Compositions for Treatment of Attention Deficit Hyperactivity Disorder
08/14/2014US20140227194 Preparation for Restenosis Prevention
08/14/2014US20140227193 Preparation for Restenosis Prevention
08/14/2014US20140227192 Preparation for Restenosis Prevention
08/14/2014US20140227185 Glutathione-based drug delivery system
08/14/2014US20140227180 Antibody-sn-38 immunoconjugates with a cl2a linker
08/14/2014US20140227179 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/14/2014US20140227174 Skin permeating and cell entering (space) peptides and methods of use therefor
08/14/2014US20140227173 Cancer treatment with gamma-secretase inhibitors
08/14/2014US20140227172 Diagnosis and treatment of prostate cancer
08/14/2014US20140225303 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
08/14/2014US20140224694 Propofol Formulations with Non-Reactive Container Closures
08/14/2014US20140224693 Propofol Formulations with Non-Reactive Container Closures
08/14/2014US20140224692 Therapeutic rinse
08/14/2014DE112012004878T5 Heterocyclische Dihydro-Fünfring-Ketonderivate als DHODH-Inhibitor und ihre Verwendung Heterocyclic dihydro-five-ring ketone derivatives as DHODH inhibitor and their use
08/14/2014DE112012003996T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use
08/13/2014EP2765196A1 Short interfering ribonucleic acid (siRNA)
08/13/2014EP2765154A1 Use of an article based on a polymeric composition
08/13/2014EP2765141A1 Compositions comprising agents that inhibit neuroplilin and tolloid like 2
08/13/2014EP2765133A1 Acylated derivative of homoharringtonine, preparation method therefor, and application thereof
08/13/2014EP2765128A1 Substituted benzamides with activity towards EP4 receptors
08/13/2014EP2764875A1 Process for preparing a stable pharmaceutical composition comprising dexketoprofen trometamol
08/13/2014EP2764874A1 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic stem cells and uses thereof
08/13/2014EP2764873A1 Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound
08/13/2014EP2764869A1 Agent for improving quality of sleep
08/13/2014EP2764867A1 Agents for preventing and treating disorders Involving modulation of the RYR receptors
08/13/2014EP2764866A1 Inhibitors of nedd8-activating enzyme
08/13/2014EP2764865A2 Cancer treatment
08/13/2014EP2764864A1 Novel anti-hcv agent
08/13/2014EP2764863A1 Tau aggregation inhibitor
08/13/2014EP2764862A1 Immediate release tablets of rasagiline hemitartrate
08/13/2014EP2764102A1 Methods and compositions for regulating hiv infection
08/13/2014EP2763998A1 Tri-heterocyclic derivatives, preparation process and uses thereof
08/13/2014EP2763997A1 Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists
08/13/2014EP2763995A1 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
08/13/2014EP2763994A2 Novel quinoxaline inhibitors of pi3k
08/13/2014EP2763992A1 NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
08/13/2014EP2763990A1 Pyrrolopyrazine kinase inhibitors
08/13/2014EP2763989A1 Pyridine compounds and uses thereof
08/13/2014EP2763986A1 Fsh receptor antagonists
08/13/2014EP2763985A1 Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors
08/13/2014EP2763984A1 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors
08/13/2014EP2763983A1 L-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p3i map kinase inhibitors
08/13/2014EP2763982A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
08/13/2014EP2763981A2 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
08/13/2014EP2763980A2 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same
08/13/2014EP2763979A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
08/13/2014EP2763978A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/13/2014EP2763977A1 Ethynyl derivatives as mglur5 allosteric modulators
08/13/2014EP2763972A1 New apoptosis inducing compounds
08/13/2014EP2763969A1 Ethynyl derivatives as metabotropic glutamate receptor modulators
08/13/2014EP2763967A1 Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via a novel intermediate
08/13/2014EP2763962A1 Methods of treatment using modulators of sirt2
08/13/2014EP2763683A1 Treatment of eosinophilic esophagitis
08/13/2014EP2763682A1 Choline composition
08/13/2014EP2763681A1 Malignant and non-malignant disease treatment with ras antagonists
08/13/2014EP2763680A1 Methods and systems for identifying and treating anti-progestin sensitive tumors
08/13/2014EP2763679A2 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion
08/13/2014EP2763678A1 Treatment of rhinitis
08/13/2014EP2763677A2 Novel imidazole quinoline-based immune system modulators
08/13/2014EP2763676A2 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
08/13/2014EP2763675A2 Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
08/13/2014EP2763674A1 Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
08/13/2014EP2763673A1 Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
08/13/2014EP2763672A1 1,3-substituted azetidine pde10 inhibitors
08/13/2014EP2763671A2 Methods of treating age related disorders
08/13/2014EP2763670A1 Reactivation of hiv-1 gene expression to treat persistent hiv infection
08/13/2014EP2763669A2 Formulations and uses of retinoic acid receptor selective agonists
08/13/2014EP2763668A1 Pharmaceutical methods and topical compositions containing acitretin
08/13/2014EP2763667A1 Organonitro thioether compounds and medical uses thereof
08/13/2014EP2763666A1 Composition comprising bacillus calmette guerin with cox2 selective/preferential inhibitor and uses thereof
08/13/2014EP2763664A2 Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
08/13/2014EP2763663A1 Pharmaceutical compositions comprising 40 - o - ( 2 - hydroxy) ethyl - rapamycin
08/13/2014EP2763662A1 Pharmaceutical compositions of antihypertensives
08/13/2014EP2763661A1 Fine dry particulate adenosine compositions and topical formulations including the same
08/13/2014EP2763655A1 Coated medical devices comprising a water - insoluble therapeutic agent and an additive
08/13/2014EP2763654A1 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
08/13/2014EP2763653A2 Personal care compositions and methods of making same
08/13/2014EP2763546A1 Gluten-free food composition and food products prepared therefrom
08/13/2014CN203763525U 奥美拉唑和碳酸氢钠包芯片 Omeprazole and sodium bicarbonate chip package
08/13/2014CN103987842A 治疗癌症的方法 Methods of treating cancer
08/13/2014CN103987718A 作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓 As a non-symmetric dimers pbd compounds for inclusion in the targeting conjugate pyrrolo benzodiazepine
08/13/2014CN103987713A 5,7-取代的咪唑并[1,2-c]嘧啶 5,7-substituted-imidazo [1,2-c] pyrimidine
08/13/2014CN103987711A 作为用于治疗癌症和免疫性和自身免疫性疾病的凋亡诱导剂的8-氨基甲酰基-2-(2,3-二取代吡啶-6-基)-1,2,3,4-四氢异喹啉衍生物 As 8-Carbamoyl for treating cancer and autoimmune diseases, and immune inducing agent apoptosis-2- (2,3-di-substituted pyridin-6-yl) -1,2,3,4- Hydrogen isoquinoline derivatives
08/13/2014CN103987710A 新的*嗪衍生物及它们在治疗疾病中的应用 * New piperazine derivatives and their use in the treatment of diseases
08/13/2014CN103987709A 用于制备可用作atr激酶抑制剂的化合物的方法 The method of preparing compounds useful as kinase inhibitors for use atr
08/13/2014CN103987708A 4-羟基-1,2,3,4-四氢萘-1-基脲的衍生物和它们在呼吸道疾病以及其它疾病的治疗中的用途 4-hydroxy-1,2,3,4-tetrahydro-naphthalen-1-yl urea derivatives and their use in the treatment of respiratory diseases and other diseases in the
08/13/2014CN103987707A 吡唑-4-基-杂环基-甲酰胺化合物以及使用方法 Pyrazol-4-yl - heterocyclyl - carboxamide compound, and use of
08/13/2014CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives
08/13/2014CN103987704A 类黄酮化合物 Flavonoids
08/13/2014CN103987699A 作为pi3k调节剂的喹唑啉衍生物 As quinazoline derivatives pi3k moderator
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103987697A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia
08/13/2014CN103987696A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia
08/13/2014CN103987406A 含有激酶抑制剂的组合物 Kinase inhibitor composition comprising
08/13/2014CN103987391A 用于净化肤色的视黄醛环糊精缩醛和半缩醛 For purifying complexion retinal cyclodextrin acetal and hemiacetal
08/13/2014CN103987390A 植物甾族化合物及其用途 Plant steroids and their use
08/13/2014CN103987389A 用于具有重度肾损害的血栓栓塞患者中血栓栓塞的预防和/或治疗剂 For thromboembolism in patients with severe renal impairment have in the prevention of thromboembolism and / or therapeutic agent
08/13/2014CN103987388A 二肽基肽酶-iv抑制剂的新晶形 The new crystalline form of dipeptidyl peptidase inhibitors -iv
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 7860